BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi H, Li K, Feng J, Liu G, Feng Y, Zhang X. LncRNA-DANCR Interferes With miR-125b-5p/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis. Front Oncol. 2020;10:1034. [PMID: 32766131 DOI: 10.3389/fonc.2020.01034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Luan L, Dai Y, Shen T, Yang C, Chen Z, Liu S, Jia J, Li Z, Fang S, Qiu H, Cheng X, Yang Z. Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer. Front Immunol 2022;13:951455. [DOI: 10.3389/fimmu.2022.951455] [Reference Citation Analysis]
2 Wang B, Tan B. Noncoding RNAs: Regulating the crosstalk between tumor-associated macrophages and gastrointestinal cancer. Biomedicine & Pharmacotherapy 2022;153:113370. [DOI: 10.1016/j.biopha.2022.113370] [Reference Citation Analysis]
3 Ren Z, Ding T, He H, Wei Z, Shi R, Deng J. Mechanism of selenomethionine inhibiting of PDCoV replication in LLC-PK1 cells based on STAT3/miR-125b-5p-1/HK2 signaling. Front Immunol 2022;13:952852. [DOI: 10.3389/fimmu.2022.952852] [Reference Citation Analysis]
4 Yan S, Wang S, Wang X, Dai W, Chu J, Cheng M, Guo Z, Xu D. Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer. Front Oncol 2022;12:954329. [DOI: 10.3389/fonc.2022.954329] [Reference Citation Analysis]
5 Zhou RT, Ni YR, Zeng FJ. The roles of long noncoding RNAs in the regulation of OCT4 expression. Stem Cell Res Ther 2022;13:383. [PMID: 35907897 DOI: 10.1186/s13287-022-03059-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ghafouri-Fard S, Khoshbakht T, Hussen BM, Baniahmad A, Taheri M, Samadian M. A review on the role of DANCR in the carcinogenesis. Cancer Cell Int 2022;22:194. [PMID: 35590326 DOI: 10.1186/s12935-022-02612-z] [Reference Citation Analysis]
7 Loren P, Saavedra N, Saavedra K, De Godoy Torso N, Visacri MB, Moriel P, Salazar LA. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. Front Pharmacol 2022;13:831099. [PMID: 35444536 DOI: 10.3389/fphar.2022.831099] [Reference Citation Analysis]
8 Gao Z, Jiang J, Hou L, Zhang B. Dysregulation of miR-144-5p/RNF187 axis contributes to the progression of colorectal cancer. Journal of Translational Internal Medicine 2022;0. [DOI: 10.2478/jtim-2021-0043] [Reference Citation Analysis]
9 Kazmierczak D, Jopek K, Sterzynska K, Nowicki M, Rucinski M, Januchowski R. The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines. Int J Mol Sci 2022;23:526. [PMID: 35008952 DOI: 10.3390/ijms23010526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang M, Gu J, Zhang X, Yang J, Zhang X, Fang X. Long Non-coding RNA DANCR in Cancer: Roles, Mechanisms, and Implications. Front Cell Dev Biol 2021;9:753706. [PMID: 34722539 DOI: 10.3389/fcell.2021.753706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Liu C, Jin Y, Fan Z. The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer. Front Oncol 2021;11:698023. [PMID: 34540667 DOI: 10.3389/fonc.2021.698023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
12 Li X, Zhang Y, Wang X, Lin F, Cheng X, Wang Z, Wang X. Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2. Cell Biol Toxicol 2021. [PMID: 34510316 DOI: 10.1007/s10565-021-09650-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Miao X, Wang F, Wang T, Razak SRA, Yunus MA, Ismail IS. Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance. 3 Biotech 2021;11:423. [PMID: 34603923 DOI: 10.1007/s13205-021-02971-w] [Reference Citation Analysis]
14 Zhang B, Chan SH, Liu XQ, Shi YY, Dong ZX, Shao XR, Zheng LY, Mai ZY, Fang TL, Deng LZ, Zhou DS, Chen SN, Li M, Zhang XD. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer. J Cell Mol Med 2021. [PMID: 34378321 DOI: 10.1111/jcmm.16842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shi H, Li K, Feng J, Zhang X. Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis. J Chemother 2021;:1-11. [PMID: 33818320 DOI: 10.1080/1120009X.2021.1906032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Micallef I, Baron B. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Noncoding RNA 2021;7:24. [PMID: 33807355 DOI: 10.3390/ncrna7020024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
17 Liu R, Wang X, Shen Y, He A. Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations. Mol Biol Rep 2021;48:2713-27. [PMID: 33704659 DOI: 10.1007/s11033-021-06247-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
18 Deng P, Sun M, Zhao WY, Hou B, Li K, Zhang T, Gu F. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis. World J Gastroenterol 2021; 27(6): 487-500 [PMID: 33642823 DOI: 10.3748/wjg.v27.i6.487] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
19 Shen Y, Sun M, Zhu J, Wei M, Li H, Zhao P, Wang J, Li R, Tian L, Tao Y, Shen P, Zhang J. Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer. Mol Omics 2021;17:464-71. [PMID: 33881127 DOI: 10.1039/d1mo00022e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]